![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:62095 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of VAPA mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:737415 | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:62095 | 6480464 | Tetrachlorodibenzodioxin affects the expression of VAPA mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of VAPA mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737415 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of VAPA mRNA | CTD | PMID:29704546 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VAPA mRNA | CTD | PMID:26232522 | 2,4,6-tribromophenol | decreases expression | ISO | RGD:737415 | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of VAPA mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of VAPA mRNA | CTD | PMID:21346803 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:737415 | 6480464 | tetrabromobisphenol A results in decreased expression of VAPA protein | CTD | PMID:31675489 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:737415 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAPA mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | affects expression | ISO | RGD:737415 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the expression of VAPA protein | CTD | PMID:31945527 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:737415 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of VAPA protein | CTD | PMID:34186270 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:737415 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of VAPA gene | CTD | PMID:31601247 | acrolein | multiple interactions | ISO | RGD:737415 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of VAPA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of VAPA mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases methylation | ISO | RGD:737415 | 6480464 | Aflatoxin B1 results in increased methylation of VAPA gene | CTD | PMID:27153756 | alpha-pinene | multiple interactions | ISO | RGD:737415 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of VAPA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of VAPA mRNA | CTD | PMID:32699268 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of VAPA mRNA | CTD | PMID:16483693 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of VAPA mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | RGD:737415 | 6480464 | Antirheumatic Agents results in increased expression of VAPA mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | RGD:737415 | 6480464 | Arsenic affects the methylation of VAPA gene | CTD | PMID:25304211 | arsane | multiple interactions | ISO | RGD:737415 | 6480464 | [Palmitic Acid co-treated with Arsenic] affects the expression of VAPA mRNA | CTD | PMID:33736254 | arsenic atom | affects methylation | ISO | RGD:737415 | 6480464 | Arsenic affects the methylation of VAPA gene | CTD | PMID:25304211 | arsenic atom | multiple interactions | ISO | RGD:737415 | 6480464 | [Palmitic Acid co-treated with Arsenic] affects the expression of VAPA mRNA | CTD | PMID:33736254 | arsenite(3-) | multiple interactions | ISO | RGD:737415 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to VAPA mRNA], arsenite promotes the reaction [G3BP1 protein binds to VAPA protein] | CTD | PMID:32406909 | benzene | increases expression | ISO | RGD:737415 | 6480464 | Benzene results in increased expression of VAPA mRNA | CTD | PMID:19162166 | benzo[a]pyrene | increases expression | ISO | RGD:62095 | 6480464 | Benzo(a)pyrene results in increased expression of VAPA mRNA | CTD | PMID:21569818, PMID:22228805 | bisphenol A | decreases expression | ISO | RGD:62095 | 6480464 | bisphenol A results in decreased expression of VAPA mRNA | CTD | PMID:26512966 | bisphenol A | increases expression | ISO | RGD:737415 | 6480464 | bisphenol A results in increased expression of VAPA protein | CTD | PMID:34186270 | bisphenol A | decreases expression | ISO | RGD:737415 | 6480464 | bisphenol A results in decreased expression of VAPA protein | CTD | PMID:31675489 | bisphenol A | multiple interactions | ISO | RGD:737415 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of VAPA gene | CTD | PMID:31601247 | bisphenol A | decreases methylation | ISO | RGD:737415 | 6480464 | bisphenol A results in decreased methylation of VAPA gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of VAPA gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of VAPA mRNA | CTD | PMID:25181051, PMID:34947998 | bisphenol F | multiple interactions | ISO | RGD:737415 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAPA mRNA | CTD | PMID:28628672 | bisphenol F | increases expression | ISO | RGD:737415 | 6480464 | bisphenol F results in increased expression of VAPA protein | CTD | PMID:34186270 | Brodifacoum | decreases expression | EXP | | 6480464 | bromfenacoum results in decreased expression of VAPA protein | CTD | PMID:28903499 | cadmium dichloride | decreases expression | ISO | RGD:737415 | 6480464 | Cadmium Chloride results in decreased expression of VAPA mRNA, Cadmium Chloride results in decreased expression of VAPA protein | CTD | PMID:25851441 | caffeine | decreases phosphorylation | ISO | RGD:737415 | 6480464 | Caffeine results in decreased phosphorylation of VAPA protein | CTD | PMID:35688186 | cisplatin | affects response to substance | ISO | RGD:737415 | 6480464 | VAPA protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | clozapine | increases expression | ISO | RGD:737415 | 6480464 | Clozapine results in increased expression of VAPA protein | CTD | PMID:34122009 | coumarin | affects phosphorylation | ISO | RGD:737415 | 6480464 | coumarin affects the phosphorylation of VAPA protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | RGD:62095 | 6480464 | Asbestos, Crocidolite results in decreased expression of VAPA mRNA | CTD | PMID:29279043 | dexamethasone | multiple interactions | ISO | RGD:737415 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAPA mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of VAPA mRNA | CTD | PMID:17379624 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of VAPA mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | RGD:737415 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | RGD:737415 | 6480464 | entinostat results in decreased expression of VAPA mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RGD:737415 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VAPA mRNA | CTD | PMID:27188386 | enzyme inhibitor | multiple interactions | ISO | RGD:737415 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of VAPA protein | CTD | PMID:23301498 | epoxiconazole | increases expression | ISO | RGD:62095 | 6480464 | epoxiconazole results in increased expression of VAPA mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | RGD:62095 | 6480464 | Ethanol results in increased expression of VAPA mRNA | CTD | PMID:30319688 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of VAPA mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | RGD:62095 | 6480464 | Folic Acid results in decreased expression of VAPA mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | RGD:737415 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of VAPA gene, [bisphenol A co-treated with Fulvestrant] results in decreased methylation of VAPA gene | CTD | PMID:31601247 | fumonisin B1 | increases expression | ISO | RGD:62095 | 6480464 | fumonisin B1 results in increased expression of VAPA mRNA | CTD | PMID:16221962 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of VAPA mRNA | CTD | PMID:33387578 | hexadecanoic acid | multiple interactions | ISO | RGD:737415 | 6480464 | [Palmitic Acid co-treated with Arsenic] affects the expression of VAPA mRNA | CTD | PMID:33736254 | hydroquinone | decreases expression | ISO | RGD:737415 | 6480464 | hydroquinone results in decreased expression of VAPA mRNA | CTD | PMID:31256213 | indometacin | multiple interactions | ISO | RGD:737415 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAPA mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:737415 | 6480464 | Ivermectin results in decreased expression of VAPA protein | CTD | PMID:32959892 | lead diacetate | decreases expression | ISO | RGD:62095 | 6480464 | lead acetate results in decreased expression of VAPA mRNA | CTD | PMID:21829687 | methyl methanesulfonate | decreases expression | ISO | RGD:737415 | 6480464 | Methyl Methanesulfonate results in decreased expression of VAPA mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | RGD:737415 | 6480464 | methylmercuric chloride results in decreased expression of VAPA mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | RGD:737415 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of VAPA mRNA more ... | CTD | PMID:32699268 | panobinostat | multiple interactions | ISO | RGD:737415 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VAPA mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | RGD:737415 | 6480464 | panobinostat results in decreased expression of VAPA mRNA | CTD | PMID:26272509 | paracetamol | affects expression | ISO | RGD:62095 | 6480464 | Acetaminophen affects the expression of VAPA mRNA | CTD | PMID:17562736 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of VAPA protein | CTD | PMID:24521700 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of VAPA mRNA | CTD | PMID:16940010 | resveratrol | increases expression | ISO | RGD:737415 | 6480464 | resveratrol results in increased expression of VAPA protein | CTD | PMID:18089832 | SB 431542 | multiple interactions | ISO | RGD:737415 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | increases expression | ISO | RGD:737415 | 6480464 | Sunitinib results in increased expression of VAPA mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | ISO | RGD:62095 | 6480464 | Carbon Tetrachloride results in increased expression of VAPA mRNA | CTD | PMID:31919559 | valproic acid | decreases expression | ISO | RGD:737415 | 6480464 | Valproic Acid results in decreased expression of VAPA mRNA | CTD | PMID:23179753, PMID:28001369 | |